Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kiora Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Kiora Pharmaceuticals

Kiora Pharmaceuticals

Public

Kiora Pharmaceuticals: A global, clinical-stage company specializing in eye disease treatments.

HQ
Encinitas, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company founded with the mission to develop and commercialize novel therapeutics aimed at treating orphan retinal diseases. The company focuses on improving sight in patients suffering from severe vision loss and addressing high unmet needs in ophthalmic health. Kiora Pharmaceuticals is publicly traded on the NASDAQ under the ticker symbol KPRX and serves a global market.

Notable affiliated individuals include key researchers and industry experts specializing in ophthalmology. The company has garnered significant attention from investors due to its innovative approach to treating rare retinal conditions. Key achievements include advancing several promising therapeutics through clinical development stages, demonstrating potential to significantly impact the quality of life for patients with severe vision impairments. Kiora Pharmaceuticals continues to make strides in ocular health, aiming to restore vision and improve overall eye health for patients worldwide.

Kiora Pharmaceuticals - Similar Companies

Alimera Sciences logo

Alimera Sciences

EyePoint logo

EyePoint

EyeCyte logo

EyeCyte

eyecyte.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Ocuphire Pharma logo

Ocuphire Pharma

ocuphire.com

Visiox logo

Visiox

visioxpharma.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Zhaoke Ophthalmology Pharmaceutical logo

Zhaoke Ophthalmology Pharmaceutical

Ocular Science logo

Ocular Science

ocularscience.com

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

OcuCure Therapeutics logo

OcuCure Therapeutics

MediPrint Ophthalmics logo

MediPrint Ophthalmics

Ocumension Therapeutics logo

Ocumension Therapeutics

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Kiora Pharmaceuticals - Quick Facts

Who are Kiora Pharmaceuticals' competitors?

Companies similar to Kiora Pharmaceuticals include Alimera Sciences, EyePoint, EyeCyte and Ocular Therapeutix.

When was Kiora Pharmaceuticals founded?

Kiora Pharmaceuticals was founded in 2004.

Where is Kiora Pharmaceuticals' headquarters located?

Kiora Pharmaceuticals' headquarters is located in Encinitas, CA, US.

When was Kiora Pharmaceuticals' last funding round?

Kiora Pharmaceuticals' most recent funding round was for $15M (USD) in January 2024.

How much has Kiora Pharmaceuticals raised to-date?

As of Jan 31, 2024, Kiora Pharmaceuticals has raised a total of $106.5M (USD).

How many employees does Kiora Pharmaceuticals have?

Kiora Pharmaceuticals has 14 employees as of Feb 6, 2024.

Kiora Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Eye Treatments
Tags
  • Biotech
Unique IDs
  • ein: 980443284
  • secCik: 0001372514
  • ticker: KPHMW
  • ticker: KPRX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research